News & Presentations Filter by Category All 70 Company News 26 Media 17 Newsletter 7 Presentations & Webinars 21 Presentations & Webinars, All Michelle Long 17/4/25 Presentations & Webinars, All Michelle Long 17/4/25 Investor Webinar April 2025 Read More Media, All Michelle Long 17/4/25 Media, All Michelle Long 17/4/25 Stockhead Special Report: Arovella tackles CAR-T’s limitations in cancer treatment Read More Company News, All Michelle Long 15/4/25 Company News, All Michelle Long 15/4/25 Redkite Heartbreak to Hope Walk Read More Media, All Michelle Long 14/4/25 Media, All Michelle Long 14/4/25 Dr Michael Baker interviewed on Tim Boreham’s Health Kick Podcast Read More Company News, All Michelle Long 14/4/25 Company News, All Michelle Long 14/4/25 Extraordinary General Meeting (2025 EGM) Read More Presentations & Webinars, All Michelle Long 24/3/25 Presentations & Webinars, All Michelle Long 24/3/25 Spark Plus Singapore Healthcare Day 2025 Presentation Read More Company News, All Michelle Long 3/3/25 Company News, All Michelle Long 3/3/25 Research Agreement with University of North Carolina Read More Company News, All Michelle Long 3/3/25 Company News, All Michelle Long 3/3/25 Letter from Managing Director and CEO Read More Company News, All Michelle Long 26/2/25 Company News, All Michelle Long 26/2/25 Arovella fully funded to complete phase 1 enrolement and generate clinical data with $15 placement Read More Presentations & Webinars, All Michelle Long 4/2/25 Presentations & Webinars, All Michelle Long 4/2/25 Dr Michael Baker presents at the Euroz Hartleys 2025 Healthcare Forum Read More Media, All Michelle Long 28/1/25 Media, All Michelle Long 28/1/25 Proactive Investor: Oncology outlook: ASX small caps driving innovation in cancer treatment Read More Media, All Michelle Long 15/1/25 Media, All Michelle Long 15/1/25 Dr Michael Baker speaks with JustStocks about $20 million funding milestone Read More Company News, All Michelle Long 10/1/25 Company News, All Michelle Long 10/1/25 Arovella fully funded to complete phase 1 with $20m placement Read More Newsletter, All Michelle Long 19/12/24 Newsletter, All Michelle Long 19/12/24 Arovella Newsletter December 2024 Read More Media, All Michelle Long 9/12/24 Media, All Michelle Long 9/12/24 MST Access analyst coverage Read More Media, All Michelle Long 5/12/24 Media, All Michelle Long 5/12/24 Dr Michael Baker interviewed on the Marcus Today podcast Read More Company News, All Michelle Long 18/11/24 Company News, All Michelle Long 18/11/24 AGM 2024 presentation and results Read More Presentations & Webinars, All Michelle Long 29/10/24 Presentations & Webinars, All Michelle Long 29/10/24 AusBioInvest presentation Read More Company News, All Michelle Long 28/10/24 Company News, All Michelle Long 28/10/24 Arovella receives R&D tax rebate of $3.0 million with a further $0.3 million expected Read More Media, All Michelle Long 22/10/24 Media, All Michelle Long 22/10/24 Dr Michael Baker interviewed by JustStocks Read More Older Posts
Presentations & Webinars, All Michelle Long 17/4/25 Presentations & Webinars, All Michelle Long 17/4/25 Investor Webinar April 2025 Read More
Media, All Michelle Long 17/4/25 Media, All Michelle Long 17/4/25 Stockhead Special Report: Arovella tackles CAR-T’s limitations in cancer treatment Read More
Company News, All Michelle Long 15/4/25 Company News, All Michelle Long 15/4/25 Redkite Heartbreak to Hope Walk Read More
Media, All Michelle Long 14/4/25 Media, All Michelle Long 14/4/25 Dr Michael Baker interviewed on Tim Boreham’s Health Kick Podcast Read More
Company News, All Michelle Long 14/4/25 Company News, All Michelle Long 14/4/25 Extraordinary General Meeting (2025 EGM) Read More
Presentations & Webinars, All Michelle Long 24/3/25 Presentations & Webinars, All Michelle Long 24/3/25 Spark Plus Singapore Healthcare Day 2025 Presentation Read More
Company News, All Michelle Long 3/3/25 Company News, All Michelle Long 3/3/25 Research Agreement with University of North Carolina Read More
Company News, All Michelle Long 3/3/25 Company News, All Michelle Long 3/3/25 Letter from Managing Director and CEO Read More
Company News, All Michelle Long 26/2/25 Company News, All Michelle Long 26/2/25 Arovella fully funded to complete phase 1 enrolement and generate clinical data with $15 placement Read More
Presentations & Webinars, All Michelle Long 4/2/25 Presentations & Webinars, All Michelle Long 4/2/25 Dr Michael Baker presents at the Euroz Hartleys 2025 Healthcare Forum Read More
Media, All Michelle Long 28/1/25 Media, All Michelle Long 28/1/25 Proactive Investor: Oncology outlook: ASX small caps driving innovation in cancer treatment Read More
Media, All Michelle Long 15/1/25 Media, All Michelle Long 15/1/25 Dr Michael Baker speaks with JustStocks about $20 million funding milestone Read More
Company News, All Michelle Long 10/1/25 Company News, All Michelle Long 10/1/25 Arovella fully funded to complete phase 1 with $20m placement Read More
Newsletter, All Michelle Long 19/12/24 Newsletter, All Michelle Long 19/12/24 Arovella Newsletter December 2024 Read More
Media, All Michelle Long 9/12/24 Media, All Michelle Long 9/12/24 MST Access analyst coverage Read More
Media, All Michelle Long 5/12/24 Media, All Michelle Long 5/12/24 Dr Michael Baker interviewed on the Marcus Today podcast Read More
Company News, All Michelle Long 18/11/24 Company News, All Michelle Long 18/11/24 AGM 2024 presentation and results Read More
Presentations & Webinars, All Michelle Long 29/10/24 Presentations & Webinars, All Michelle Long 29/10/24 AusBioInvest presentation Read More
Company News, All Michelle Long 28/10/24 Company News, All Michelle Long 28/10/24 Arovella receives R&D tax rebate of $3.0 million with a further $0.3 million expected Read More
Media, All Michelle Long 22/10/24 Media, All Michelle Long 22/10/24 Dr Michael Baker interviewed by JustStocks Read More
